1. Chen, Kai-Lin, Huang, Sai-Wei, Yao, Ji-Jin, Ma, Jun, Liu, Na. 2024. LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein. In Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 76, 101111. doi:10.1016/j.drup.2024.101111. https://pubmed.ncbi.nlm.nih.gov/38908233/
2. Zhu, Huijun, Yue, Haiying, Xie, Yiting, Zhou, Yanhua, Liu, Wenqi. . Bioinformatics and integrated analyses of prognosis-associated key genes in lung adenocarcinoma. In Journal of thoracic disease, 13, 1172-1186. doi:10.21037/jtd-21-49. https://pubmed.ncbi.nlm.nih.gov/33717590/
3. Balasubramanian, Diana, Pearson, John F, Kennedy, Martin A. 2018. Gene expression effects of lithium and valproic acid in a serotonergic cell line. In Physiological genomics, 51, 43-50. doi:10.1152/physiolgenomics.00069.2018. https://pubmed.ncbi.nlm.nih.gov/30576260/
4. Pietrantoni, Gianfranco, Gaete-Argel, Aracelly, Herrera-Rojo, Diego, Valiente-Echeverría, Fernando, Arriagada, Gloria. 2021. Dynein Light-Chain Dynlrb2 Is Essential for Murine Leukemia Virus Traffic and Nuclear Entry. In Journal of virology, 95, e0017021. doi:10.1128/JVI.00170-21. https://pubmed.ncbi.nlm.nih.gov/33980598/
5. Xia, Pengcheng, Chen, Jing, Bai, Xiaohui, Wang, Le, Lu, Zhiming. 2022. Key gene network related to primary ciliary dyskinesia in hippocampus of patients with Alzheimer's disease revealed by weighted gene co-expression network analysis. In BMC neurology, 22, 198. doi:10.1186/s12883-022-02724-z. https://pubmed.ncbi.nlm.nih.gov/35637434/
智鼠故事 
